Changes in Beneficial Ownership · 4
Geron Corporation
GERNNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
form4-11162026_041101.xml
Filing details
- Report period
- 2026-11-13
- Issuer
- GERON CORP
- Issuer CIK
- 0000886744
- Trading symbol
- GERN
Reporting owner 1
- Name
- Semerjian Harout
- Reporting owner CIK
- 0001809747
- Relationship
- Director · Officer
- Officer title
- President & CEO
- Address
- C/O GERON CORPORATION, 919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-11-13 | P · Form 4 | 53,500 | A | .95[F1] | 53,500 | D |
Table key
- P · Form 4
- Purchase on the market or privately
- A
- Acquired
- D
- Direct
Footnotes
- F1
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9516 to $0.95470, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.↩ 1
Signature 1
- Signed
- Michelle Robertson, Attorney-in-Fact for Harout Semerjian
- Date
- 2026-11-16
Company context
meaningful moments for people living with blood cancer. Because patients cannot wait, we approach our work with urgency, bringing together deep expertise in telomerase biology with patient perspectives and insights from clinical research and real-world care. Our medicine, RYTELO® (imetelstat), is approved in the United States and European Union for certain patients with lower-risk myelodysplastic syndromes (LR-MDS). Geron is a commercial-stage company with offices in Parsippany, New Jersey and Foster City, California. To learn more, visit www.geron.com or follow us on LinkedIn.